“Economic evaluation of temsirolimus on the basis of the results of the ARCC (Advanced Renal-Cell Carcinoma) study”, FE, vol. 10, no. 2, pp. 93–97, Jun. 2009, doi: 10.7175/fe.v10i2.167.